North American Prodromal Synucleinopathy Consortium Stage 2

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
REM Sleep Behavior DisorderParkinson DiseaseLewy Body DementiaDementia With Lewy BodiesMultiple System AtrophyREM Sleep Parasomnias
Trial Locations (9)

30322

RECRUITING

Emory University, Atlanta

55414

RECRUITING

University of Minnesota, Minneapolis

55905

RECRUITING

Mayo Clinic Rochester, Rochester

63110

RECRUITING

Washington University School of Medicine, St Louis

90095

RECRUITING

University of California Los Angeles, Los Angeles

94063

RECRUITING

Stanford University, Redwood City

97239

RECRUITING

Oregon Health Sciences University, Portland

02145

RECRUITING

Massachusetts General Hospital, Boston

H4A 3J1

RECRUITING

McGill University Health Centre Research Institute, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

University of Minnesota

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

McGill University

OTHER

collaborator

Emory University

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Stanford University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Oregon Health and Science University

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Washington University School of Medicine

OTHER

NCT05826457 - North American Prodromal Synucleinopathy Consortium Stage 2 | Biotech Hunter | Biotech Hunter